돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 89554생성일: 2026년 10월 25일

1,2-Cyclopentanedicarboxylate

TRANS-1,2-CYCLOPENTANEDICARBOXYLIC ACID · 1,2-Cyclopentane DiforMic Acid · trans-DL-Cyclopentane-1,2-dicarb · Transpentane-1,2-dicarboxylic acid · 1,2-cyclopentane dicarboxylic acid · trans-2-cyclopentanedicarboxylicacid · rans-Cyclopentane-1,2-dicarboxylicaci · 1,2-CYCLOPENTANEDICARBOXYLIC ACID:98+%

https://huagongshe.com/ko/chemical/89554

1,2-Cyclopentanedicarboxylate 분자 구조식

식별자 및 물리적 특성

CAS No.1461-97-8
분자식C7H10O4
평균 분자량158.15 g/mol
단동위원소 질량158.0579088 g/mol
SMILESO=C(O)C1CCCC1C(=O)O
InChIKeyASJCSAKCMTWGAH-UHFFFAOYSA-N
PubChem CID89554
EC No.633-363-4
DTXSIDDTXSID40944515

화학 및 물리적 성질

XLogP0.3
극성 표면적74.6
수소 결합 공여자 수2
수소 결합 수용자 수4
회전 가능 결합 수2
무거운 원자 수11
형식 전하0
복잡도167
녹는점163-165 °C(lit.)
끓는 점46-49 °C(Press: 110 Torr)
밀도1.396±0.06 g/cm3(Predicted)
저장 조건Sealed in dry,Room Temperature
용해도DMSO메탄올 에 용해됨
pKa(산도 계수)pK1:3.96pK2:5.85 (25°C)
물리적 상태고체
색상회백색
InChIInChI=1/C7H10O4/c8-6(9)4-2-1-3-5(4)7(10)11/h4-5H,1-3H2,(H,8,9)(H,10,11)/t4-,5-/s3
InChIKeyASJCSAKCMTWGAH-GADJSHNENA-N
SMILES[C@@H]1(C(O)=O)CCC[C@H]1C(O)=O |&1:0,7,r|
EPA1,2-Cyclopentanedicarboxylic acid, (1R,2R)-rel- (1461-97-8)

화학적 성질

off-white powder

안전 및 규제

GHS 분류DangerH302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesAcute Tox. 4 (97.5%)
수질 위해 등급(WGK)3
TSCA 등재 상태TSCA listed
관세 코드2917200090
저장 분류11 - Combustible Solids

용도

용도

trans-1,2-Cyclopentanedicarboxylic Acid is used as a reagent in the synthesis of isoxazoline and oxazoline analogs of CDA54 as voltage gated sodium channel blockers. trans-1,2-Cyclopentanedicarboxylic Acid is also a reagent in the preparation of cyclopentanedicarboxamide sodium channel blockers as a potential treatment for chronic pain.